Tylan Templin, Christopher D Riehm, Travis Eliason, Tessa C Hulburt, Samuel T Kwak, Omar Medjaouri, David Chambers, Manish Anand, Kase Saylor, Gregory D Myer, Daniel P Nicolella
{"title":"Evaluation of drop vertical jump kinematics and kinetics using 3D markerless motion capture in a large cohort.","authors":"Tylan Templin, Christopher D Riehm, Travis Eliason, Tessa C Hulburt, Samuel T Kwak, Omar Medjaouri, David Chambers, Manish Anand, Kase Saylor, Gregory D Myer, Daniel P Nicolella","doi":"10.3389/fbioe.2024.1426677","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>3D Markerless motion capture technologies have advanced significantly over the last few decades to overcome limitations of marker-based systems, which require significant cost, time, and specialization. As markerless motion capture technologies develop and mature, there is increasing demand from the biomechanics community to provide kinematic and kinetic data with similar levels of reliability and accuracy as current reference standard marker-based 3D motion capture methods. The purpose of this study was to evaluate how a novel markerless system trained with both hand-labeled and synthetic data compares to lower extremity kinematic and kinetic measurements from a reference marker-based system during the drop vertical jump (DVJ) task.</p><p><strong>Methods: </strong>Synchronized video data from multiple camera views and marker-based data were simultaneously collected from 127 participants performing three repetitions of the DVJ. Lower limb joint angles and joint moments were calculated and compared between the markerless and marker-based systems. Root mean squared error values and Pearson correlation coefficients were used to quantify agreement between the systems.</p><p><strong>Results: </strong>Root mean squared error values of lower limb joint angles and joint moments were ≤ 9.61 degrees and ≤ 0.23 N×m/kg, respectively. Pearson correlation values between markered and markerless systems were 0.67-0.98 hip, 0.45-0.99 knee and 0.06-0.99 ankle for joint kinematics. Likewise, Pearson correlation values were 0.73-0.90 hip, 0.61-0.95 knee and 0.74-0.95 ankle for joint kinetics.</p><p><strong>Discussion: </strong>These results highlight the promising potential of markerless motion capture, particularly for measures of hip, knee and ankle rotations. Further research is needed to evaluate the viability of markerless ankle measures in the frontal plane to determine if differences in joint solvers are inducing unanticipated error.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"12 ","pages":"1426677"},"PeriodicalIF":4.3000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540714/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1426677","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: 3D Markerless motion capture technologies have advanced significantly over the last few decades to overcome limitations of marker-based systems, which require significant cost, time, and specialization. As markerless motion capture technologies develop and mature, there is increasing demand from the biomechanics community to provide kinematic and kinetic data with similar levels of reliability and accuracy as current reference standard marker-based 3D motion capture methods. The purpose of this study was to evaluate how a novel markerless system trained with both hand-labeled and synthetic data compares to lower extremity kinematic and kinetic measurements from a reference marker-based system during the drop vertical jump (DVJ) task.
Methods: Synchronized video data from multiple camera views and marker-based data were simultaneously collected from 127 participants performing three repetitions of the DVJ. Lower limb joint angles and joint moments were calculated and compared between the markerless and marker-based systems. Root mean squared error values and Pearson correlation coefficients were used to quantify agreement between the systems.
Results: Root mean squared error values of lower limb joint angles and joint moments were ≤ 9.61 degrees and ≤ 0.23 N×m/kg, respectively. Pearson correlation values between markered and markerless systems were 0.67-0.98 hip, 0.45-0.99 knee and 0.06-0.99 ankle for joint kinematics. Likewise, Pearson correlation values were 0.73-0.90 hip, 0.61-0.95 knee and 0.74-0.95 ankle for joint kinetics.
Discussion: These results highlight the promising potential of markerless motion capture, particularly for measures of hip, knee and ankle rotations. Further research is needed to evaluate the viability of markerless ankle measures in the frontal plane to determine if differences in joint solvers are inducing unanticipated error.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.